arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Autolus Therapeutics plc

AUTL

$1.31 ▼ -0.07 (-5.07%) at close

31 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Autolus Therapeutics plc faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $348.7M

Dividend Yield —

Revenue Growth 118.4% ↘

Op. Margin -95.9% ↗

ROIC -59.3% ↘

FCF / Share $-0.10 ↗

Trailing P/E —

Price / Book 4.7x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

31-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$45.69M

↑ +118.4% —

Net Income Profit after all expenses

$-71.60M

↓ -2.0% —

Operating Margin Operating profit as % of sales

-95.9%

↑ +57.7% 0th

FCF / Share Free cash flow per share

$-0.10

↑ +67.5% —

Long-Term Debt Long-term obligations

$0.00

↓ -100.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability

Returns ↓

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q4 FY2020 Dec 31, 2020 20-F ↗	Q4 FY2019 Dec 31, 2019 20-F ↗	Q4 FY2018 Dec 31, 2018 20-F ↗	Q3 FY2018 Sep 30, 2018 20-F ↗	Q1 FY2018 Sep 30, 2018 20-F ↗	Q4 FY2017 Sep 30, 2017 20-F ↗	Q3 FY2017 Sep 30, 2017 20-F ↗	Q1 FY2017 Sep 30, 2017 20-F ↗	Q4 FY2016 Sep 30, 2016 20-F ↗	Q3 FY2016 Sep 30, 2016 20-F ↗	Q1 FY2016 Sep 30, 2016 20-F ↗	Q4 FY2015 Sep 30, 2015 20-F ↗	Q3 FY2015 Sep 30, 2015 20-F ↗
Revenue Growth YoY (%)	118.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1380%)	191.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2299%)	83655.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1045590%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-86.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1179%)	—	—	39.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+396%)	—	—	—	—	—
EPS Growth YoY (%)	16.7% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-3.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-277.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	3.2% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	18.2% Good → Good Stable Year-over-year change in earnings per share Optimal: > 10%	-8.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	80.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-19.2% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	15.4% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-4.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-95.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	44.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-2.0% Weak ↑ Weak Improving Year-over-year change in net income	-2.0% Weak ↑ Weak Improving Year-over-year change in net income	-227.2% Weak ↓ Weak Declining Year-over-year change in net income	3.6% Caution ↑ Caution Improving Year-over-year change in net income	-33.2% Weak ↓ Weak Declining Year-over-year change in net income	-33.2% Weak ↓ Weak Declining Year-over-year change in net income	64.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-79.1% Weak ↑ Weak Improving Year-over-year change in net income	-32.4% Weak ↑ Weak Improving Year-over-year change in net income	-32.4% Weak ↑ Weak Improving Year-over-year change in net income	-186.3% Weak Weak Year-over-year change in net income	-7.2% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—	—	—	—	61.9% Excellent Excellent Year-over-year change in net income	—	—	-57.2% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	67.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	18.9% Good ↑ Good Improving Year-over-year change in free cash flow	—	16.3% Good ↑ Good Improving Year-over-year change in free cash flow	-54.1% Weak → Weak Stable Year-over-year change in free cash flow	-70.5% Weak ↓ Weak Declining Year-over-year change in free cash flow	—	-35.4% Weak ↓ Weak Declining Year-over-year change in free cash flow	20.2% Good Good Year-over-year change in free cash flow	30.2% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q4 FY2020 Dec 31, 2020 20-F ↗	Q4 FY2019 Dec 31, 2019 20-F ↗	Q4 FY2018 Dec 31, 2018 20-F ↗	Q3 FY2018 Sep 30, 2018 20-F ↗	Q1 FY2018 Sep 30, 2018 20-F ↗	Q4 FY2017 Sep 30, 2017 20-F ↗	Q3 FY2017 Sep 30, 2017 20-F ↗	Q1 FY2017 Sep 30, 2017 20-F ↗	Q4 FY2016 Sep 30, 2016 20-F ↗	Q3 FY2016 Sep 30, 2016 20-F ↗	Q1 FY2016 Sep 30, 2016 20-F ↗	Q4 FY2015 Sep 30, 2015 20-F ↗	Q3 FY2015 Sep 30, 2015 20-F ↗
Operating Margin (%) (%)	-95.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-740%)	-227.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1613%)	-298.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2089%)	-337.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2353%)	-292.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2051%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	-1.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.7% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.8% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-3.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-5.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-262.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	12.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	15.7% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	15.6% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	12.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—
Profit Margin (%) (%)	-156.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1406%)	-273.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2376%)	-371.9% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3199%)	-373.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3211%)	-335.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2894%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-56.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-259.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-280.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-341.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-382.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.36x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.14x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.19x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.78x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.05x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.34x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.16x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—	2.38x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	0.98x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q4 FY2020 Dec 31, 2020 20-F ↗	Q4 FY2019 Dec 31, 2019 20-F ↗	Q4 FY2018 Dec 31, 2018 20-F ↗	Q3 FY2018 Sep 30, 2018 20-F ↗	Q1 FY2018 Sep 30, 2018 20-F ↗	Q4 FY2017 Sep 30, 2017 20-F ↗	Q3 FY2017 Sep 30, 2017 20-F ↗	Q1 FY2017 Sep 30, 2017 20-F ↗	Q4 FY2016 Sep 30, 2016 20-F ↗	Q3 FY2016 Sep 30, 2016 20-F ↗	Q1 FY2016 Sep 30, 2016 20-F ↗	Q4 FY2015 Sep 30, 2015 20-F ↗	Q3 FY2015 Sep 30, 2015 20-F ↗
Return on Invested Capital (%)	-59.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-55.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-40.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-18.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-47.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-14.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-26.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-23.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Return on Capital (%) (%)	-8.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-12.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-8.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-9.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-4.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-14.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-4.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	-95.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-738%)	-65.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-539%)	-50.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-438%)	-29.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-299%)	-20.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-235%)	-18.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-226%)	-6.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-143%)	-17.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-215%)	-10.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-167%)	-9.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-160%)	-69.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-562%)	-25.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-269%)	-17.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-216%)	-14.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-199%)	-16.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-211%)	-26.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-277%)	—	—	—	—	—	—	-5.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-136%)	—	—	—	—	—	—	—	—

⚖️ Is the balance sheet risky? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q4 FY2020 Dec 31, 2020 20-F ↗	Q4 FY2019 Dec 31, 2019 20-F ↗	Q4 FY2018 Dec 31, 2018 20-F ↗	Q3 FY2018 Sep 30, 2018 20-F ↗	Q1 FY2018 Sep 30, 2018 20-F ↗	Q4 FY2017 Sep 30, 2017 20-F ↗	Q3 FY2017 Sep 30, 2017 20-F ↗	Q1 FY2017 Sep 30, 2017 20-F ↗	Q4 FY2016 Sep 30, 2016 20-F ↗	Q3 FY2016 Sep 30, 2016 20-F ↗	Q1 FY2016 Sep 30, 2016 20-F ↗	Q4 FY2015 Sep 30, 2015 20-F ↗	Q3 FY2015 Sep 30, 2015 20-F ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	0.01x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-99%)	0.01x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-99%)	—	—	—	—	—	—
Interest Coverage (x)	-16.39x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-5.35x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3.17x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6.81x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-8.96x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-6.43x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-2.46x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6.35x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-5.79x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-2.01x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1.77x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.56x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-8.84x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-7.98x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3.37x Weak Weak Operating income divided by interest expense Optimal: > 5x	-23.51x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-171.41M	$-130.93M	$-104.13M	$-86.12M	$-123.83M	$-95.80M	$-227.38M	$-657.07M	$-705.94M	$-758.53M	$-239.57M	$-256.42M	$-307.50M	$-343.03M	$-163.05M	$-163.05M	—	$-310.34M	—	$0.00	$285.00K	$380.00K	—	$763.00K	$763.00K	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q4 FY2020 Dec 31, 2020 20-F ↗	Q4 FY2019 Dec 31, 2019 20-F ↗	Q4 FY2018 Dec 31, 2018 20-F ↗	Q3 FY2018 Sep 30, 2018 20-F ↗	Q1 FY2018 Sep 30, 2018 20-F ↗	Q4 FY2017 Sep 30, 2017 20-F ↗	Q3 FY2017 Sep 30, 2017 20-F ↗	Q1 FY2017 Sep 30, 2017 20-F ↗	Q4 FY2016 Sep 30, 2016 20-F ↗	Q3 FY2016 Sep 30, 2016 20-F ↗	Q1 FY2016 Sep 30, 2016 20-F ↗	Q4 FY2015 Sep 30, 2015 20-F ↗	Q3 FY2015 Sep 30, 2015 20-F ↗
Revenue per Share (USD)	$0.17	$0.10	—	$0.08	$0.08	$0.03	—	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.15	$-0.27	$-0.34	$-0.30	$-0.18	$-0.26	$-0.09	$-0.31	$-0.22	$-0.24	$-0.45	$-0.26	$-0.26	$-0.23	$-0.23	$-0.47	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.10	$-0.26	—	$-0.27	$-0.30	$-0.31	—	$-0.32	$-0.20	$-0.18	—	$-0.24	$-0.24	$-0.26	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.28	$0.41	—	$1.00	$1.30	$1.39	—	$1.79	$1.98	$2.62	—	$1.04	$1.32	$1.54	—	$1.77	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$0.28	$0.41	—	$1.00	$1.30	$1.39	—	$1.79	$1.98	$2.62	—	$1.04	$1.32	$1.54	—	$1.77	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	266.16M	266.14M	—	266.14M	266.14M	266.13M	—	266.08M	266.03M	222.17M	—	173.98M	173.86M	173.83M	—	91.24M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q4 FY2020 Dec 31, 2020 20-F ↗	Q4 FY2019 Dec 31, 2019 20-F ↗	Q4 FY2018 Dec 31, 2018 20-F ↗	Q3 FY2018 Sep 30, 2018 20-F ↗	Q1 FY2018 Sep 30, 2018 20-F ↗	Q4 FY2017 Sep 30, 2017 20-F ↗	Q3 FY2017 Sep 30, 2017 20-F ↗	Q1 FY2017 Sep 30, 2017 20-F ↗	Q4 FY2016 Sep 30, 2016 20-F ↗	Q3 FY2016 Sep 30, 2016 20-F ↗	Q1 FY2016 Sep 30, 2016 20-F ↗	Q4 FY2015 Sep 30, 2015 20-F ↗	Q3 FY2015 Sep 30, 2015 20-F ↗
Working Capital (USD)	$267.30M	$305.24M	$362.48M	$431.51M	—	$549.16M	$600.19M	—	—	$760.31M	$230.56M	—	—	—	$173.49M	—	—	$280.62M	$163.35M	$224.27M	$211.89M	$242.14M	—	$137.45M	$137.45M	—	—	—	—	—	—
LT Debt (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$0.00	$285.00K	$380.00K	—	$763.00K	$763.00K	—	—	—	—	—	—
Total Equity (USD)	$74.84M	$108.83M	$178.13M	$265.45M	$346.46M	$371.11M	$427.32M	$476.96M	$527.84M	$582.03M	$111.47M	$180.52M	$229.34M	$266.92M	$161.15M	$161.15M	$214.52M	$313.32M	$210.03M	$254.84M	$255.47M	$255.47M	$137.51M	$142.60M	$142.60M	—	$30.69M	$30.69M	—	$10.50M	$10.50M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q4 FY2020 Dec 31, 2020 20-F ↗	Q4 FY2019 Dec 31, 2019 20-F ↗	Q4 FY2018 Dec 31, 2018 20-F ↗	Q3 FY2018 Sep 30, 2018 20-F ↗	Q1 FY2018 Sep 30, 2018 20-F ↗	Q4 FY2017 Sep 30, 2017 20-F ↗	Q3 FY2017 Sep 30, 2017 20-F ↗	Q1 FY2017 Sep 30, 2017 20-F ↗	Q4 FY2016 Sep 30, 2016 20-F ↗	Q3 FY2016 Sep 30, 2016 20-F ↗	Q1 FY2016 Sep 30, 2016 20-F ↗	Q4 FY2015 Sep 30, 2015 20-F ↗	Q3 FY2015 Sep 30, 2015 20-F ↗
Sales/Revenue/Turnover (USD)	$45.69M	$26.22M	$24.29M	$21.19M	$20.92M	$8.98M	$29.00K	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	$231.00K	—	—	$1.69M	—	—	$1.21M	—	—
Depreciation Expense (USD)	$2.16M	$2.21M	$2.14M	$2.08M	$2.08M	$1.99M	$1.92M	$1.94M	$1.90M	$1.81M	$1.77M	$1.38M	$1.51M	$1.90M	$1.65M	$1.80M	—	—	—	—	—	—	$1.71M	—	—	$1.01M	—	—	$478.00K	—	—
Net Income, GAAP (USD)	$-71.60M	$-71.60M	$-90.33M	$-79.12M	$-70.16M	$-70.16M	$-27.61M	$-82.09M	$-52.69M	$-52.69M	$-77.17M	$-45.85M	$-39.81M	$-39.81M	$-26.95M	$-42.77M	—	—	—	—	—	—	$-7.52M	—	—	$-19.73M	—	—	$-12.55M	—	—
Operating Cash Flow (USD)	$-25.07M	$-65.32M	$-67.32M	$-67.90M	$-72.78M	$-75.56M	$-37.93M	$-76.74M	$-51.08M	$-40.51M	$-24.83M	$-40.19M	$-38.15M	$-42.42M	$-14.57M	—	—	—	—	—	—	—	$-8.80M	—	—	$-16.36M	—	—	$-9.85M	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 11 years · 31 quarters

Autolus Therapeutics plc

Analytical Summary

31-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare AUTL with peers